Showing results (211-220 of 276) with videos related to
Sort By:
Pageof 28
Bioorganic & Medicinal Chemistry Letters|January 12, 2010
Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agentsZilun Hu, Xiangjun Jiang, Charles F Albright, et al.Journal of Intensive Care Medicine|December 13, 2021
Bag-Mask Ventilation Versus Apneic Oxygenation During Tracheal Intubation in Critically Ill Adults: A Secondary Analysis of 2 Randomized TrialsErin M Vaughan, Kevin P Seitz, David R Janz, et al.Journal of the American Geriatrics Society|April 4, 2017
Use of Medications of Questionable Benefit at the End of Life in Nursing Home Residents with Advanced DementiaJeremy N Matlow, Susan E Bronskill, Andrea Gruneir, et al.Journal of the American Geriatrics Society|July 29, 2017
Frailty and Potentially Inappropriate Medication Use at Nursing Home TransitionLaura C Maclagan, Colleen J Maxwell, Sima Gandhi, et al.Journal of Medical Internet Research|May 27, 2018
Computer-Based Driving in Dementia Decision Tool With Mail Support: Cluster Randomized Controlled TrialMark J Rapoport, Carla Zucchero Sarracini, Alex Kiss, et al.Journal of Intensive Care Medicine|January 9, 2025
Oxygen Targets for Mechanically Ventilated Adults with Sepsis: Secondary Analysis of the PILOT TrialJack C Shapiro, Jonathan D Casey, Edward T Qian, et al.JAMA|March 19, 2024
Individualized Treatment Effects of Oxygen Targets in Mechanically Ventilated Critically Ill AdultsKevin G Buell, Alexandra B Spicer, Jonathan D Casey, et al.Molecular Therapy. Advances|June 19, 2026
Deep-sequencing-guided library screening and profiling of AAV capsids in the primate retinaYoussef Fouani, Dragica Blazevic, Martin Oti, et al.Proceedings of the National Academy of Sciences of the United States of America|March 14, 2018
Immune-modulating enzyme indoleamine 2,3-dioxygenase is effectively inhibited by targeting its apo-formMicah T Nelp, Patrick A Kates, John T Hunt, et al.Journal of Medicinal Chemistry|May 24, 1996
Preparation and structure-activity relationship of novel P1/P1'-substituted cyclic urea-based human immunodeficiency virus type-1 protease inhibitorsD A Nugiel, K Jacobs, R F Kaltenbach, et al.Pageof 28